Omaveloxolone (RTA-408)
99%
- Product Code: 62090
CAS:
1474034-05-3
| Molecular Weight: | 554.71 g./mol | Molecular Formula: | C₃₃H₄₄F₂N₂O₃ |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | -20℃ |
Product Description:
Omaveloxolone is primarily investigated for its potential therapeutic applications in treating mitochondrial diseases and inflammatory conditions. It functions as an activator of Nrf2, a transcription factor that regulates antioxidant response, helping to reduce oxidative stress and inflammation in cells. This makes it a promising candidate for conditions like Friedreich's ataxia, a genetic disorder that leads to progressive nervous system damage and movement issues. Additionally, its anti-inflammatory properties are being explored for other neurodegenerative diseases and conditions where oxidative stress plays a key role in disease progression. Clinical trials are ongoing to evaluate its efficacy and safety in these areas.
Product Specification:
| Test | Specification |
|---|---|
| APPEARANCE | White Powder |
| PURITY | 98.5-100 |
| Infrared spectrum | Conforms to Structure |
| NMR | Conforms to Structure |
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.005 | 10-20 days | ฿8,990.00 |
+
-
|
| 0.025 | 10-20 days | ฿28,990.00 |
+
-
|
| 0.100 | 10-20 days | ฿76,000.00 |
+
-
|
Omaveloxolone (RTA-408)
Omaveloxolone is primarily investigated for its potential therapeutic applications in treating mitochondrial diseases and inflammatory conditions. It functions as an activator of Nrf2, a transcription factor that regulates antioxidant response, helping to reduce oxidative stress and inflammation in cells. This makes it a promising candidate for conditions like Friedreich's ataxia, a genetic disorder that leads to progressive nervous system damage and movement issues. Additionally, its anti-inflammatory properties are being explored for other neurodegenerative diseases and conditions where oxidative stress plays a key role in disease progression. Clinical trials are ongoing to evaluate its efficacy and safety in these areas.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :